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Although sepsis is the leading cause of death from infection, there are few population-level
epidemiological sepsis reports. The impact of sepsis-related deaths on all-cause hospital
mortality is insufficiently described, in particular in Europe where data are non-existent. The
objective of this study was to provide nationwide epidemiological results on sepsis hospitali-
zations in Norway and to estimate sepsis’ contribution to overall hospital mortality in a Euro-
pean setting.
Methods
We performed a retrospective study using data from the Norwegian Patient Registry and
Statistics Norway. The occurrence, patient characteristics and outcomes of sepsis hospitali-
zations during the years 2011 and 2012 were estimated and compared with Norwegian pop-
ulation data. Sepsis was defined as organ dysfunction caused by a dysregulated host
response to infection and identified with International Classification of Diseases 10th revision
codes.
Results
We identified 18 460 sepsis admissions occurring in 13 582 individuals. The annual popula-
tion incidence of hospitalized sepsis was 140 patients per 100 000 inhabitants; ranging from
10 to 2270 per 100 000 in different age groups and with statistically significant male predom-
inance in all adult cohorts. Hospital mortality for sepsis admissions was 19.4% and overall,
26.4% of the included patients died while hospitalized for sepsis. Sepsis related deaths con-
stituted 12.9% of all hospital fatalities, while hospitalizations with sepsis accounted for 1.0%
of the total number of admissions and 3.5% of the total admission days during 2011 and
2012.
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Conclusions
This study confirms that hospitalized sepsis is frequent in Norway and a major contributor to
hospital fatalities in a European setting. The incidence is higher among men than women.
Sepsis is in particular a disease of the elderly, and its impact on health-care will assumingly
continue to increase in parallel with an aging population. Improvements in treatment and
survival of sepsis could influence population mortality, and sepsis should receive greater
attention in official death statistics in the future.
Introduction
Sepsis is the leading cause of death from infection and a major public health concern in most
countries. Still, the epidemiology of this condition is insufficiently described. Population-level
results on the incidence of hospital-treated sepsis exist for only eight countries around the
world, including Norway as one of four European sites [1, 2]. The currently available Norwe-
gian study is however from the year 1999, and thus of uncertain validity as the occurrence and
outcome of sepsis has changed during the last decades [1, 3]. Hence, this study was conducted
to gain updated results on the epidemiology of sepsis hospitalizations in Norway. Furthermore,
a secondary objective was to investigate sepsis’ contribution to hospital fatalities, which previ-
ously has been surveyed in the United States (U.S.) only [4]. Since we were able to extract
information from all Norwegian hospitals, we present the first estimate of sepsis’ impact on
overall hospital mortality from complete nationwide data.
Materials and methods
This was a retrospective study combining hospitalization data from the Norwegian Patient
Registry (NPR) and population data from Statistics Norway [5, 6]. The years 2011 and 2012
were chosen because these were the most recent years from which complete data were available
when the study was conceived. The NPR is a national database run by the Norwegian Director-
ate of Health, containing information about all hospital admissions in Norway (patient data,
dates of hospitalization, type of hospital and department, vital status at discharge and Interna-
tional Classification of Diseases 10th revision (ICD-10) discharge codes). Reporting to the NPR
is mandatory. In the current study, a primary search throughout the years 2011 and 2012 was
performed by use of selected ICD-10 discharge codes for infections, systemic inflammatory
response syndrome (SIRS), sepsis by causative microbes, and septic shock (Table 1). In this
primary cohort, we then searched for the presence of up to eight additional ICD-10 discharge
codes indicating acute organ dysfunction. Sepsis was defined as life-threatening organ dys-
function caused by a dysregulated host response to infection, inspired by the Third Interna-
tional Consensus Definitions for Sepsis and Septic Shock [7]. Accordingly, the final study
cohort consisted of cases fulfilling one or several infection or sepsis related ICD-10 codes as
well as one or several codes for acute organ dysfunction (Fig 1).
The NPR database was used to obtain data regarding hospital stay (days), outcome (hospital
mortality), age and gender. Information about the total number and total duration of somatic
hospital stays in Norway during the years 2011 and 2012 was also collected from the NPR,
while national population data including total number of hospital deaths were retrieved from
Statistics Norway. The extracted patient data were transferred to a local database (FileMaker,
Inc, Pro 14.0; Santa Clara, CA, U.S.). In patients with more than five admissions during the
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Table 1. ICD-10 codes used in this study.





A21.7 Sepsis (generalized) tularemic
A22.7 Anthrax sepsis




A40 (.0, 1, 2, 3, 8, 9) Streptococcal sepsis





A48.3 Toxic shock syndrome
A54.8 Other gonococcal infections
B37.7 Candidal sepsis
J09 Influenza due to identified zoonotic or pandemic influenza virus
J10 Influenza due to identified seasonal influenza virus
J13 Pneumonia due to Streptococcus pneumoniae
J14 Pneumonia due to Haemophilus influenzae
J15 Bacterial pneumonia, not elsewhere classified
J18 (.0, 1, 2, 8, 9) Pneumonia, unspecified microbiology
J36 Peritonsillar abscess
J39 Other diseases of upper respiratory tract





N10 Acute tubulo-interstitial nephritis
O85 Puerperal sepsis
P36 Bacterial sepsis of newborn
R57.2 Septic shock
R65 (.0, 1, 9) Systemic Inflammatory Response Syndrome [SIRS] of infectious origin without
(.0) or with organ dysfunction (.1), or not further specified (.9)
T81.4 Infection following a procedure
Organ dysfunctions
R57 Shock
I50.9 Heart failure, unspecified
J80 Adult respiratory distress syndrome
J95 Postprocedural respiratory disorders
J96.0 Acute respiratory failure
N17 Acute renal failure
N99.0 Postprocedural renal failure
D65 Disseminated intravascular coagulation [defibrination syndrome]
D69 Purpura and other haemorrhagic conditions
(Continued )
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study period, the 6.th admission(s) were excluded from analyses. In the presentation of the
results, descriptive statistics for continuous variables are given as mean ± standard deviation
(SD) or median and interquartile range (IQR). Annual population incidence of hospitalized
sepsis was calculated as the number of patients experiencing one or more sepsis episode(s)
during 2011 and 2012, divided by the sum of the total number of inhabitants in Norway during
the same years. Population incidence by age and gender was compared by incidence rate ratios
(IRRs) with 95% confidence intervals (CIs). Survival is illustrated by Kaplan-Meier plots and
was compared between groups with log rank tests. A p-value 0.05 was considered statisti-
cally significant. The statistical analyses were performed using IBM SPSS Statistics (version
23.0; Aramonk, NY, U.S.); with the exception of the IRRs which were computed with MedCalc
for Windows (version 12.7; Ostend, Belgium).
Ethics approval
The study was approved by the Regional Committee for Medical and Health Research Ethics
in Western Norway, with a waiver of informed consent (case number 2014/1922).
Results
During the years 2011 and 2012, we identified 18 460 sepsis admissions occurring in 13 582
individuals in Norway. Hospitalizations with sepsis constituted 1.0% of the total number of
somatic hospital admissions (n = 1 767 535, Fig 1), and the annual population incidence of
hospitalized sepsis was 140 per 100 000 inhabitants. The incidence showed a great age depen-
dent increase; from 10 to 2270 patients per 100 000 inhabitants per year in different age groups
(Fig 2). The increase was more pronounced among men, who reached a maximum age-specific
annual incidence of 3430 per 100 000 inhabitants, while the corresponding rate for women
was 1880 per 100 000. However, significant gender disparities in incidence rates were found
across all adult age categories, starting from 20–29 years and upwards (S1 Table).
Characteristics of the study cohort are presented in Table 2. In total 82.8% of patients
were 60 years and the respiratory tract was the most common site of infection. Two or
more acute organ dysfunctions were documented in 14.7% of cases. The hospital mortality for
sepsis admissions was 19.4%, and overall during the study period 26.4% of the included
patients died while hospitalized for sepsis. Hospital mortality increased with age (Fig 3A, log
rank p< 0.001) and number of organ dysfunctions (Fig 3B, log rank p< 0.001).
The total number of hospital deaths in Norway during 2011 and 2012 was 27 705, and
deaths during hospital stays for sepsis constituted 12.9% of all hospital fatalities (Table 3). Fur-
thermore, hospitalizations with sepsis accounted for 3.5% of the total admission days during
the same period.
Discussion
This nationwide retrospective register-based study from 2011 and 2012 confirms that sepsis is
frequent and often fatal in Norwegian hospitals. The overall annual population incidence was
Table 1. (Continued)
ICD-10 code a Diagnosis
K72 Hepatic failure
E87.2 Acidosis
a Norwegian version, URL https://finnkode.ehelse.no/#icd10/0/0/0/-1
https://doi.org/10.1371/journal.pone.0187990.t001
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Fig 1. Diagram of the inclusion process.
https://doi.org/10.1371/journal.pone.0187990.g001
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140 per 100 000 inhabitants, showed a considerable age dependent increase, and was highest
among males. Sepsis admissions occupied 3.5% of the total admission days and had a mortality
rate of 19.4%. The observed number of deaths corresponded to 12.9% of the total number of
hospital fatalities during the study period, which to our knowledge is the first estimate of sep-
sis’ impact on overall hospital mortality from complete nationwide data.
The definition of sepsis was recently changed, and the term severe sepsis abandoned [7]. To
facilitate the interpretation of our results, we use the word sepsis as synonymous with the new
definition throughout the following discussion (i.e. life-threatening organ dysfunction caused
by a dysregulated host response to infection).
This is the second nationwide retrospective study of sepsis in Norway. Compared with pre-
vious data, the most notable difference is an almost threefold increase in the annual population
incidence which was estimated to 50 per 100 000 inhabitants in the year 1999 [3]. Other epide-
miological studies of sepsis in Norway is restricted to a single-center, prospective study per-
formed by the current authors in 2008 [8, 9]. Then, we detected an incidence of community
acquired sepsis of 50 per 100 000 inhabitants per year. It is plausible that these observations
reflect an ongoing trend of increasing sepsis occurrence, attributed to a growing number of
individuals at risk for severe infection [10–13]. Register-based studies are additionally likely
influenced by changes in coding patterns [14]. However, we included both codes for severe
infections, SIRS, sepsis by causative microbes, and septic shock in our primary search. Thus
influence of a potential shift in coding towards more frequent use of sepsis specific codes was
limited.
Throughout the last two decades there have been numerous international publications on
the epidemiology of sepsis. Yet, only eight countries have reported population-level incidences
Fig 2. Age-specific annual incidence of sepsis hospitalizations by gender in Norway 2011–2012. Significant gender differences in incidence rate
ratios were found starting from category 20–29 years and upwards, as shown in S1 Table.
https://doi.org/10.1371/journal.pone.0187990.g002
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and only four previous studies from Europe are performed with nationwide data [1–3, 11, 15,
16]. It is well known that there are large differences in previous reports of sepsis occurrence,
which partly may be explained by different study designs [1, 10, 17, 18]. Overall, our current
results are in line with two recent nationwide European studies as well as a population-based
study from China, while the most recent studies from the U.S. tend to report higher estimates
Table 2. Characteristics of patients with sepsis in Norwegian hospitals 2011–2012.
Characteristic N (% of total) a
Gender b
Male 7 327 (53.9%)
Female 6 255 (46.1%)
Age b
Median (IQR) 78 (21)
Mean ± SD 73 ± 18
ICD-10 codes found in the primary search c, d
Respiratory infections 12 932 (70.1%)
Soft tissue infections 899 (4.9%)
Genitourinary infections 822 (4.5%)
Abdominal infections 798 (4.3%)
Infection following a procedure 641 (3.5%)
Streptococcal sepsis 557 (3.0%)
Other sepsis (A41) 5 092 (27.6%)
SIRS (R65.0,1 or 9) 1 087 (5.9%)
Septic shock 735 (4.0%)
Other 159 (0.9%)
Organ dysfunctions c
Cardiovascular 8 944 (48.5%)
Respiratory 5 907 (32.0%)
Renal 4 597 (24.8%)
Hematologic 1 659 (9.0%)
Hepatic 436 (2.4%)
Metabolic 259 (1.4%)
Number of organ dysfunctions c
1 15 750 (85.3%)
2 2 198 (11.9%)
3 416 (2.3%)
 4 96 (0.5%)
Length of stay, days c
Median (IQR) 9 (12)
Mean ± SD 14 ± 19
Hospital mortality b
Total 3 620 (26.4%)
Male 2 021 (27.6%)
Female 1 565 (25.0%)
a if not otherwise specified.
b calculated from total number of patients hospitalized with one or more sepsis episode(s) (n = 13 582).
c calculated from total number of sepsis admissions (n = 18 460).
d in total 23 722 primary diagnostic codes were identified; patients could have more than one code.
https://doi.org/10.1371/journal.pone.0187990.t002
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[2, 11, 13, 15, 19–21]. This may reflect differences in health care systems as well as ICD-coding
practices [17]. Also, studies from the U.S. tend report incidence as the number of sepsis admis-
sions per unit of population older than18 years of age. If we use the same criteria, our corre-
sponding rate was e.g. 270 per 100 000 population in the year 2012.
We found a slight predominance of males in our study. There was in particular a higher
age-specific incidence of sepsis in males compared to females among the elderly, but signifi-
cant differences in incidence rate ratios were present in all adult cohorts. Possible explanations
for gender disparities in sepsis have been reviewed elsewhere [17], as similar age and gender
differences in sepsis occurrence have been observed [2, 15, 22–24]. In line with studies of
trends in sepsis epidemiology, our mean age of 72 years is higher than the equivalent of 58
years found in the previous nationwide report from Norway [3, 11, 23, 25]. The high average
age among our patient population furthermore corresponds to recent results [11, 13, 24]. The
elderly is especially predisposed to sepsis due to their high prevalence of chronic diseases, poly-
pharmacy, repeated hospitalizations, functional loss, malnutrition, common residencies in
long-term care facilities and, of course, due to age-related immunosenescence itself. Yet there
is no doubt that the registered hospitalizations among the oldest patients represent cases of
severe and resource demanding illness, these circumstances indicate that the elderly on aver-
age will have a greater number of diagnostic codes per hospital stay. This probably leads to a
greater chance of false positive sepsis cases by use of a code-based identification strategy, and
Fig 3. Hospital mortality for sepsis admissions in Norway 2011–2012. Kaplan-Meier plots illustrating hospital mortality for sepsis admissions in Norway
during 2011 and 2012, according to A. different age cohorts and B. number of affected organ systems.
https://doi.org/10.1371/journal.pone.0187990.g003
























2011 4 920 305 878 368 8 069 596 704 6 574 3 806 900 124 792 14 088 1 795
2012 4 985 870 889 167 10 391 601 456 7 008 3 667 016 139 679 13 617 1 791
Sum 9 906 175 1 767 535 18 460 1 198 160 13 582 7 473 916 264 471 27 705 3 586
If not otherwise specified, data represents number of cases (n =)
https://doi.org/10.1371/journal.pone.0187990.t003
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estimation of sepsis incidence is therefore especially prone to uncertainty in this subgroup of
patients.
Respiratory tract infections dominated among the infectious sources of sepsis in our
patients. Most of the previous register-based studies do not specify the distribution of infection
codes. However, similar results were found in the U.S. in 1995, and respiratory tract infection
was the most frequent infection category in recent prospective studies from both emergency
department and intensive care unit settings, as well as in our previous prospective study from
Norway [8, 22, 26, 27].
The number of organ dysfunctions among our patients is in the lower range compared to
previous nationwide figures from Spain and the U.S. [11, 13, 20, 21]. Case inclusion in these
retrospective studies was performed with fewer ICD-codes for infection and additional codes
for organ dysfunction. This may have resulted in selection of more severely ill patient popula-
tions [19, 28–30]. Of interest is a Swedish study that evaluated previously used approaches for
database extraction and found a lower presence of multiple organ dysfunctions among their
Swedish cohort than in two reference publications from the U.S. [16, 22, 23]. Nevertheless,
these findings do not reveal whether the apparent lower disease burden of sepsis in Scandina-
via actually is a true reflection of the disease, or a bias from a pattern of under-coding. Previous
prospective reports from Scandinavia have found a higher occurrence of multiple organ dys-
functions, but they are single-center studies from large University Hospitals [9, 26]. Prospec-
tive registration is inevitably superior in this setting, as it does not rely on compliance during
discharge coding. In addition, we excluded dysfunction of the central nervous system which
was present in 30–34% of the prospectively identified Scandinavian cases, due to lack of a dis-
tinct ICD-10 code.
Hospital mortality for sepsis admissions was 19.4% in our study, and 26.4% of the cohort
died while hospitalized for sepsis. This is consistent with other similar recent international
studies [13, 24]. Further, hospital mortality from sepsis in Norway has decreased from the pre-
vious estimation of 27.1%; despite an increase in mean age and a co-occurring decrease in the
mean number of admission days [3]. The latter has also been noted elsewhere [11, 13, 20].
We found that sepsis contributed to 12.9% of the total number of hospital deaths during the
study period. This is in contrast to the official cause of death statistics in Norway, where sepsis
is only superficially described in the annual report based on death certificates [31]. Similarly,
the corresponding report in the U.S. specifies sepsis to have caused 1.5% of all deaths in the
year 2014, while a retrospective investigation of hospital mortality showed that sepsis contrib-
uted to 1 in every 2 to 3 deaths [4, 32]. Both of these U.S. estimates include patients without
organ dysfunction. If we use the number of deaths found in our primary cohort (i.e. hospital
fatalities among the patients with selected codes for infection, sepsis or SIRS, n = 8186), our
corresponding number is 29.5%. With the exception of the mentioned retrospective report,
we found no previous literature on sepsis’ influence on total hospital mortality [4]. Other
researchers have used multiple causes of death data to assess the impact of sepsis on popula-
tion-level all-cause mortality [33–36].This approach underestimates sepsis-related mortality
compared with administrative datasets [37].
The aforementioned findings illustrate important difficulties in sepsis surveillance and
reporting. Several authors have reviewed approaches for code-based identification of sepsis.
Many have advised against limitation of discharge codes to diagnoses specific for sepsis and
septic shock. This has been found to yield more severely ill patient populations than prospec-
tive settings, and underestimate sepsis incidence [19, 28, 30]. Furthermore, a prospective
survey of sepsis in the medical emergency department at a Danish University Hospital re-iden-
tified only one in seven cases with a subsequent search based on ICD-codes [26]. The latter
results are undoubtedly notable, yet the prospective inclusion is subject to some limitations
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such as lack of verification of sepsis beyond the ED, and an unusual distribution of organ fail-
ure (65.1% had respiratory failure, denoted as SpO2 < 92% at admission, versus only 7.4–9.2%
with cardiovascular and renal failure). Just recently, a Swedish study evaluated three retro-
spective strategies including the previously used Norwegian method, against an intensive care
unit registry [38]. In this context, one should note that all of the evaluated methods were
designed prior to the introduction of specific codes for SIRS and sepsis with organ dysfunc-
tion. Although an incomplete amount of patients was identified by the Norwegian approach, it
was found to be the superior strategy [3, 22, 23].
Limitations
The main limitation of this study is its retrospective, code-based design [16, 17, 19]. In short, it
encumbers our results with uncertainties due to 1) its reliance on physicians’ ability to recog-
nize sepsis, 2) its susceptibility to under-documentation of sepsis per se and/or of accompa-
nying clinical findings, and, oppositely, 3) its susceptibility to identify false positive cases
because codes for organ dysfunction not necessarily originate from infection. Likewise, fatali-
ties could be caused by another co-occurring condition. Nevertheless, our results are similar to
contemporary results from a comprehensive manual review of all medical records of a Chinese
population [2]. Ideally we should have used a prospective design. This is unfortunately not fea-
sible on a national level, besides, recent data highlights that even case-based identification of
sepsis may be subject to high variability [39]. We confined our search to infections of a certain
severity in addition to the sepsis specific codes, and used a modest selection of acute organ dys-
functions based on the previously applied method in Norway. In light of the above discussion,
we therefore consider our current criteria for inclusion reasonable.
Conclusions
This nationwide study of sepsis in Norwegian hospitals shows an increasing occurrence com-
pared with previous data from 1999, while hospital mortality still is considerably high. Sepsis
should be recognized as an important contributor to hospital deaths, and receive attention in
official reports in the future. Improvements in treatment and survival could influence popula-
tion mortality. This is highly relevant, as there is reason to assume that the annual number of
hospitalizations and deaths from sepsis will continue to increase due to an aging population.
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